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Abstract: Supramolecular hydrogels offer interesting opportunities for co-assembly with drugs
towards sustained release over time, which could be achieved given that the drug participates
in the hydrogel nanostructure, and it is not simply physically entrapped within the gel matrix.
DLeu-Phe-Phe is an attractive building block of biomaterials in light of the peptide’s inherent
biocompatibility and biodegradability. This study evaluates the assembly of the tripeptide in the
presence of either of the anti-inflammatory drugs ketoprofen or naproxen at levels analogous to
commercial gel formulations. Fourier-transformed infrared (FT-IR), circular dichroism, Thioflavin
T fluorescence, transmission electron microscopy (TEM), and oscillatory rheometry are used. Drug
release over time is monitored by means of reverse-phase high performance liquid chromatography,
and shows different kinetics for the two drugs.
Keywords: peptides; D-amino acids; chirality; hydrogels; drugs; release; self-assembly; co-assembly;
naproxen; ketoprofen
1. Introduction
Supramolecular hydrogels, and especially those formed by short peptides, have attracted increasing
interest as innovative vehicles for drug loading and release, especially if sustained or on demand [1]. Their
obvious advantages over other classes of gelators include ease of preparation, low cost, fine control over
molecular composition, inherent biocompatibility, biodegradability, and possibility for biomimicry [2].
Such advantages become more prominent in the case of minimalist systems composed of up to three
amino acids that can easily be prepared also by liquid-phase methods [3]. Tripeptides composed of both
D- and L-amino acids are particularly attractive, as they may allow for specific peptide conformation,
increased resistance towards protease degradation, and at times even unexpected bioactivity, relative
to their homochiral L-counterparts [4–7]. Other approaches to increase gelator resistance to enzymatic
hydrolysis include the use of N-aromatic derivatization [8–10], and can be combined with other
approaches, such as the use of dehydro (∆) amino acids [11,12].
Traditionally, drugs have been physically entrapped in a polymer matrix; however, an initial burst
is typically observed, and generally the release occurs rapidly if the drug simply diffuses out of the
matrix [13]. Sustained delivery can occur by design, e.g., through the engineering of hydrogel nanopore
size, through the use of microparticles, or if the drug is engaged with the hydrogel matrix, i.e., through
non-covalent or covalent bonds that can be hydrolysed [14]. A recent approach is co-assembly, whereby
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the drug participates with a gelator in the supramolecular nanostructured gel [15]. In this case, release
happens slowly as the nanostructures disassemble. However, for co-assembly to occur, a number
of physico-chemical requirements need to be met, of which only a few can be anticipated, since it is
not yet exactly known how gelator molecules behave through the self-assembly process, and to what
extent can they tolerate other molecules (e.g., drug cargo). Naproxen and other drugs were effectively
engaged through hydrogen bonding in a supramolecular hydrogel [16]. The neurotransmitter γ-amino
isobutyrric acid (GABA) was proposed to bridge non-covalently between Fmoc-lysine molecules of a
supramolecular hydrogel [17].
In the realm of self-assembled, ultrashort (≤4 amino acids) peptide hydrogels, several examples
have been reported for drug loading and release, simply based on physical entrapment [18–21]. Drug
covalent conjugation was also shown to be possible and to not compromise self-assembly [22], for
instance for 5-fluorouracil Fmoc-Lys-Lys conjugates [23]. The phosphorylated D-peptide derivative
Nap-DPhe-DPhe-DLys-DTyr(P) is a convenient precursor of the hydrogelator Nap-DPhe-DPhe-DLys-DTyr,
since it can be enzymatically dephosphorylated by a phosphatase, but it is resistant toward
protease-mediated hydrolysis. The compound presents a primary amine on the side chain of lysine
that can be used to bind drugs, such as an anti-HIV prodrug [24] or taxol [25]. Taxol itself was used as
self-assembling motif, bound through a linker to the reduced form of the glutathione tripeptide [26].
Naproxen is yet another drug that was used as a self-assembling template bound to DPhe-DPhe,
DPhe-DPhe-DLys, or DPhe-DPhe-DLys-DTyr thanks to its aromatic character and rigid, hydrophobic
structure [27].
In line with principle, it should also be possible to engage drugs in non-covalent interactions,
and thus co-assembly with an ultrashort peptide, so that the release kinetics would be determined by
nanostructure disassembly. However, considering the small molecular weight of ultrashort peptides
(<1 kDa), it is apparent how their co-assembly with a drug would be heavily influenced by the
drug, and thus be challenging to fine-tune. Indeed, to our knowledge, there is only one reported
example of co-assembly between a drug and an (unprotected) tripeptide gelator resulting in a markedly
different nanostructure morphology relative to the peptide alone, where drug–peptide interaction
was established by spectroscopy [15]. In this case, DLeu-Phe-Phe was dissolved with hydrophobic
ciprofloxacin at alkaline pH and it gelled upon a pH trigger to neutral. It was proposed that pi–pi
interactions between the two hydrophobic, aromatic compounds played a key role in co-assembly,
although other interactions of ionic nature or hydrogen bonding could not be excluded. Importantly, a
sustained drug release was achieved, with just over 40% of the drug being delivered over 6 days [15].
DLeu-Phe-Phe was shown to co-assemble into hydrogels of different nanostructure also with rhodamine
dye, and similarly to the case above, the spectroscopic signature, nanomorphology, and viscoelastic
properties were affected [28]. In both studies, the small molecules displayed an aromatic core and both
amine and carboxylic acid functional groups (Figure 1, top), which may play a role in establishing
non-covalent interactions with the peptide during assembly.
In an attempt to shed further light on the interesting phenomenon of co-assembly for sustained
drug delivery, we thus chose for this study the anti-inflammatory drugs naproxen and ketoprofen
(Figure 1, bottom), which have a very similar structure and hydrophobicity (i.e., an octanol-water
partition coefficient, logKow, of 3.18 and 3, respectively) [29]. This work would allow investigators
to evaluate whether an ionizable carboxylic group and an aromatic core are indeed sufficient to
allow co-assembly with the peptide, and whether the conjugated pi-system of the naphthalene unit
of naproxen displays a net advantage, relative to the two benzene rings (not fused together) of
ketoprofen, to interact with the tripeptide. Another aspect that could be assessed by comparing
these two molecules is the importance of the stereoconfiguration at the chiral centre, being naproxen
enantiomerically pure, while ketoprofen a racemic mixture. Finally, both drugs are formulated as
hydrogels in commercial products, and thus they constitute a model of potential relevance in terms of
the future application of peptide hydrogels as drug delivery vehicles. Therefore, this work evaluates
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the assembly of DLeu-Phe-Phe into hydrogels in the presence of either naproxen or ketoprofen, at the
same loading level as commercial products, towards sustained drug release.Gels 2017, 3, 29  3 of 12 
 
 
Figure 1. Chemical structures of drug model compounds evaluated for co-assembly with the peptide 
DLeu-Phe-Phe in previous studies (top) and this study (bottom). * denotes the chiral centre of the 
racemic mixture that composes ketoprofen. 
2. Results and Discussion 
The tripeptide DLeu-Phe-Phe is an established gelator in phosphate buffer at neutral pH. In a 
typical protocol, it is first dissolved at pH 12 thanks to repulsion between the negatively charged 
peptide molecules, then it rapidly self-assembles as the pH is lowered to neutral and the peptide 
becomes zwitterionic [15]. Ketoprofen or naproxen were thus dissolved in the alkaline buffer as 
sodium salts, and were mixed with the peptide prior to assembly to favour their subsequent 
incorporation into the supramolecular structure. In order to assess the potential applicability of the 
resulting soft materials as drug delivery vehicles, each drug was loaded at the level typically found 
in commercial formulations, i.e., 25 and 100 mg/mL, respectively. 
2.1. Hydrogel Characterisation 
Self-supporting hydrogels were obtained in both cases, as confirmed by oscillatory rheometry 
(Figure 2). The elastic modulus G′ of the peptide hydrogel was significantly lowered upon the 
inclusion of ketoprofen, from 9 to 3 kPa, indicating the formation of a softer hydrogel. Interestingly, 
a minor difference in G′ was observed upon the inclusion of naproxen (G′ = 6 kPa), despite this drug 
being loaded at a fourfold higher level. The kinetics of assembly were not affected by the addition of 
either drug, while the resistance to applied stress was notably reduced. Indeed, the viscoelastic 
moduli of the peptide hydrogel maintained linearity up to 60 Pa, which was reduced to 15 Pa upon 
the addition of either drug. This rheological behavior overall was thus significantly different when 
compared to DLeu-Phe-Phe hydrogels co-assembled with either ciprofloxacin [15] or rhodamine [28]. 
In such cases, the elastic modulus G′ was also lowered: we can hypothesise that in all cases, the 
presence of cargo disrupts the bundling of fibrils into thicker fibers as it happens for the peptide 
alone, possibly because of an altered fibril surface topography. However, in both of the literature 
examples [15,28], hydrogel resistance to applied stress was increased upon the inclusion of cargo, 
suggesting that the presence of either a drug or dye effectively increased the interconnectivity of the 
supramolecular fiber network (as confirmed by TEM). By contrast, the soft materials of this study 
containing either naproxen or ketoprofen likely display fewer connection points between fibrils 
relative to the peptide alone, thus the lowered resistance to applied stress. 
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Figure 2. Oscillatory rheometry analysis of hydrogels (a–c) frequency sweeps; (d–f) time sweeps;  
(g–i) stress sweeps. 
2.2. Nanostructure Morphology 
Transmission electron microscopy (TEM) was thus employed to evaluate differences in 
nanomorphology that could explain the different viscoelastic properties discussed above (Figure 3). 
In all cases, a dense network of fibers was observed. Individual fibrils displayed a narrow diameter 
distribution, with minor, but statistically significant, differences between samples with or without 
either drug. In fact, fibrils formed by the peptide alone were 9.8 ± 1.4 nm wide, and became thinner 
upon the inclusion of either drug (i.e., 7.3 ± 1.0 nm for the peptide with ketoprofen, and 8.3 ± 2.2 nm 
for the peptide with naproxen). Importantly, and only in the case of peptide alone, fibrils intertwined 
into bundles as thick as 30 nm, which could provide branching points, thus increasing the resistance 
of the hydrogel network to applied stress, in agreement with the rheometric data. Thicker bundles 
could also explain the higher stiffness registered for the peptide hydrogel. 
 
Figure 3. TEM micrographs of (a) peptide hydrogel, (b) peptide hydrogel with ketoprofen, and (c) 
peptide hydrogel with naproxen. Scale bar = 50 nm. 
Figure 2. Oscillatory rheometry analysis of hydrogels (a–c) frequency sweeps; (d–f) time sweeps;
(g–i) stress sweeps.
2.2. Nanostructure Morphology
Transmission electron microscopy (TEM) was thus employed to evaluate differences in
nanomorphology that could explain the different viscoelastic properties discussed above (Figure 3).
In all cases, a dense netw rk of fibers was observed. Individual fibrils di played a narro diameter
distribution, with minor, but statistically sign ficant, diff rences between samples with or without
either drug. I fact, fibrils formed by the peptide alone wer 9.8 ± 1.4 nm wid , and became thinner
upon the inclusion of either drug (i.e., 7.3 ± 1.0 nm for the peptide with ketoprofen, and 8.3 ± 2.2 nm
for the peptide with naproxen). Importantly, and only in the case of peptide alone, fibrils intertwined
into bundles as thick as 30 nm, which could provide branching points, thus increasing the resistance of
the hydrogel network to applied stress, in agreement with the rheometric data. Thicker bundles could
also explain the higher stiffness registered for the peptide hydrogel.
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It is interesting to compare the TEM micrographs of these systems relative to those in the literature,
where DLeu-Phe-Phe is assembled in the presence of other components. Nanomorphological behaviour
is strikingly similar to the case of both hydrophilic rhodamine dye [28] or carbon nanodots (displaying
carboxylic acid and amine groups on their surface) [30] that were dissolved/dispersed with the
peptide in the alkaline buffer. By contrast, when DLeu-Phe-Phe was co-assembled with hydrophobic
ciprofloxacin, the fibers’ nanomorphology was markedly different, showing nanospheres attached to
the fibrils, and fibrils with a notably increased level of branching relative to the peptide alone [15].
We propose that, as suggested by the rheology data, the most likely scenario, in the presence of other
components dissolved with the peptide prior to assembly, involves peptide stacking in a similar
fashion as when it is alone, although the second component likely changes fibril surface topography
and thus hampers bundling into thicker fibers, lowering the elastic modulus. Instead, a significantly
different nanomorphology was achieved only in the case of hydrophobic ciprofloxacin, suggesting this
drug has the required properties to engage at a deeper level in the assembly process with the peptide.
2.3. Spectroscopic Study of Peptide Conformation
Circular dichroism (CD) spectroscopy was employed to assess changes in peptide conformation
upon assembly in the presence of either drug (Figure 4). Overall, the kinetics of assembly were
not significantly altered by either drug’s inclusion in the system, in agreement with the rheometric
data. The main features of the characteristic CD signature of the peptide in its supramolecular
state were also maintained in all cases, although quantitative effects were observed. In particular,
the negative signal for the amide bond in the 200–220 nm region that corresponds to the peptide
conformation was more intense upon the addition of ketoprofen, although the relative intensities of the
negative peaks at 205, 216 and 219 nm were preserved. Instead, all peaks were more intense upon the
addition of naproxen, and also their relative intensities were different, with the minimum at 205 nm
being the most affected, and reaching nearly twofold intensity. This data suggests that the peptide
backbone did not significantly change conformation upon the inclusion of ketoprofen, although the
surrounding chiral environment was slightly altered. Assembly in the presence of naproxen led to more
significant changes, suggesting variations also in peptide conformation. Heating ramps up to 80 ◦C
instead indicated that all materials displayed analogous thermoresistance, with the supramolecular
signal being completely lost at 60 ◦C in all cases. Therefore, despite the observed differences in the
peptide chiral environment, overall drug inclusion did not compromise the thermostability of the
supramolecular assemblies.
If we compare the CD data with the literature, we can see that the most similar case is the
one of DLeu-Phe-Phe assembled in the presence of carbon nanodots [30], whereby the 1–2 nm-wide
components altered quantitatively, but not qualitatively, the CD signal in the 200–220 nm region.
However, in that case, the minimum at 205 nm was reduced, and the others at 216 and 219 nm
were increased. This data suggests that CD is extremely sensitive at revealing changes in the chiral
environment of the peptide, which can be affected in different ways depending on the chemical nature
of the other components present in the system. Very different was the case of rhodamine dye [28] or
ciprofloxacin [15] that altered also qualitatively the peptide CD signature in the 200–220 nm region,
suggesting more interactions with the peptide, and thus affecting the local environment of the peptide
amide bonds.
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present in a sample. Indeed, controls containing either drug did not display any fluorescence at all. 
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Interestingly, the samples containing naproxen displayed only a 4% reduction in fluorescence relative 
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assembly, while systems with ketoprofen likely display significantly less amyloid surface area 
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fibril surface. It is worth noting that naproxen is enantiomerically pure, while ketoprofen is a racemic 
mixture, thus one enantiomer may engage less favourably in interactions with the chiral peptide. 
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Fourier-Transformed Infrared (FT-IR) spectroscopy was then used to verify any significant
difference in the peptide signal in the amide I region that may indicate altered peptide conformation
during assembly in the presence of either drug. However, it should be noted that the drugs were present
at notably higher amounts relative to the peptide (i.e., sixfold in weight for ketoprofen, and 24-fold in
weight for naproxen), therefore the drug signal completely dominated the IR spectrum (see Figure S1).
Thioflavin T fl ore cence was next used to evaluate chang s in the am loid supramolecular structure
(Figure 5). The dye is w dely used to quantify amyl id presence, s nce it is known to later lly bind to the
hydrophob c grooves of amyloid fibrils composed of at least f ur-consecutive beta-sheets [31]. Upon
binding, the red ced rotati n of the single bond that connects the two aromatic units composing the
dye leads t marked fluorescenc , which is not observed in the absence of amyloids [32]. Fluorescence
intensity is thus used to quantify the number of amyloid fibrils present in a sample. Indeed, controls
containing either drug did not display any fluorescence at all. By contrast, all hydrogel samples
displayed marked fluorescence upon Thioflavin T binding. Interestingly, the samples containing
naproxen displayed only a 4% reduction in fluorescence relative to the peptide alone. The samples
containing ketoprofen displayed a notable 51% reduction of the signal. This data suggests that
naproxen inclusion in the system does not compromise amyloid assembly, while systems with
ketoprofen likely display significantly less amyloid surface area available for Thioflavin T binding,
which could be the result of a lower number of fibrils or an altered fibril surface. It is worth noting that
naproxen is enantiomerically pure, while ketoprofen is a racemic mixture, thus one enantiomer may
engage less favourably in interactions with the chiral peptide.
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Figure 5. Thioflavin T fluorescence assay.
2.4. Drug Release Studies
Drug release was monitored over a 6-day period (Figure 6) at physiological conditions (i.e.,
phosphate-buffered saline solutions at 37 ◦C, with mild shaking), by using high-performance liquid
chromatography (HPLC). Ketoprofen sodium salt has a water solubility at pH 7 corresponding to
approximately 600 mg/mL [33], while naproxen sodium salt has a water solubility of 334 mg/mL at
37 ◦C [34]. Therefore, despite the high loading of the hydrogel formulations described in this work,
both drugs were well below their solubility limit, and the release experiments were carried out in
sink conditions.
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of geometry, the hydrogels analysed in this work adhered to the b ttom of the vials, so that release
effectively occurred only in the vertical direction through t e hydrogels’ top surface onto the medium
above. Sink conditions were maintained throughout the experiment as mentioned above. It should also
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be noted that the tripeptide hydrogels described in this work did not undergo visible swelling, which
is not expected considering that they were formed from phosphate-buffered solutions and phosphate
buffer is also the release medium. It is also interesting to note that, from a purely mathematical point
of view, the linear relationship observed between cumulative drug release and the square root of time
is also found in the Higuchi model. However, the underlying theoretical assumptions of the Higuchi
model are not valid for this work, and thus its application in this context would be inappropriate [37].
In the case of ketoprofen (Figure 6c,d), despite this drug being loaded at one-quarter in weight
relative to the case of naproxen described above, the release followed much faster kinetics, suggesting
less interaction with the hydrogel matrix. Indeed, drug release was completed during the first 24 h,
after which time further release was negligible. Interestingly, in this case, the best fit for the release of
up to 70% of the drug followed first-order kinetics, as typically observed for matrix-type devices [38].
Despite the drug being present as a racemic mixture, no two-step process was observed to suggest a
different level of interaction between each enantiomer and peptide. Therefore, we can conclude that
the drug interaction, observed by the spectroscopic, microscopic, and mechanical means described
above, is not very specific and likely plays a minor role in the release process.
3. Conclusions
Rational design towards the co-assembly of small molecule drugs and a simple, unprotected
tripeptide into supramolecular hydrogels for sustained release poses many challenges. In this work,
we demonstrated that it is possible to assemble a tripeptide into a hydrogel at physiological conditions
with an amount of drug corresponding to commercial formulations, both in the case of ketoprofen
and naproxen. The drugs were not just physically entrapped in the hydrogel matrix, since significant
changes relative to the peptide hydrogel without drugs were observed by oscillatory rheometry, TEM,
CD, FT-IR, and Thioflavin T fluorescence. Ketoprofen appeared to have a major impact on the ability
of the peptide to form thicker bundles of fibrils, as reflected by Thioflavin T fluorescence and rheology.
Naproxen appeared to have an impact also on peptide conformation, whilst the fibrils were slightly
thicker relative to ketoprofen, and overall the amyloid character and the hydrogel stiffness were more
similar to the peptide hydrogel without a drug.
Drug release studies highlighted differences between the two materials, since they did not
follow analogous kinetics. Remarkably, despite naproxen being loaded at a fourfold higher level
relative to ketoprofen, the naproxen-containing hydrogel showed slower release kinetics that fitted
the Ritger–Peppas empirical model for the initial 70% of the drug release over 3 days. By contrast,
ketoprofen followed more typical first-order kinetics, and overall drug delivery was more rapid as it
mainly occurred during the first 24 h. It is highly possible that the naphthalene unit of naproxen is
more efficient than the benzene rings of ketoprofen at engaging in non-covalent interactions with the
aromatic units of the peptide. Indeed, the phenylalanine residues of DLeu-Phe-Phe were hypothesised
to form hydrophobic zippers [39], also found in other short peptide systems [40], and generally in
amyloids [41]. It is well-established that naproxen covalently bound to peptides plays an adjuvant role
in self-assembly driven by hydrophobic interactions in water [27], as well as similar derivatives of the
naphthalene unit [9,42,43]. If we consider the high level of conjugation displayed by the other small
molecules able to engage with DLeu-Phe-Phe in supramolecular structures (Figure 1), we can conclude
that aromatic rings not fused together, as in the case of ketoprofen, are unlikely to be as successful for
co-assembly to occur.
4. Materials and Methods
4.1. Materials
The 2-chlorotrytil resin, O-Benzotriazole-N,N,N,N′-tetramethyl-uronium-hexafluoro-phosphate
(HBTU), and Fmoc protected N-trityl-L-histidine and D-phenylalanine were purchased from GL
Biochem (Shanghai) Ltd. (Shanghai, China). All solvents were purchased of analytical grade from
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Merck (Milan, Italy). Drugs and chemicals were from Sigma (Milan, Italy). High purity Milli-Q-water
(MQ water) with a resistivity greater than 18 MΩ·cm was obtained from an in-line Millipore
RiOs/Origin system (Merck, Milan, Italy). The 1H-NMR spectra were recorded at 400 MHz, and the
13C-NMR spectra were recorded at 100 MHz on a Varian Innova Instrument (Agilent Technologies,
Milan, Italy) with chemical shift reported as ppm (in dimethyl sulfoxide (DMSO) with tetramethylsilane
as internal standard). ESI-MS spectra were recorded on an Infinity 6120 single quadrupole LC-MS
system (Agilent Technologies, Milan, Italy).
4.2. Peptide Synthesis and Purification
The peptide was synthesised using standard Fmoc solid phase peptide synthesis with HBTU
activation. Briefly, Fmoc-amino acid deprotection was performed in a sintered funnel, with continuous
stirring, in 20% piperidine in N,N-dimethylformamide (DMF) for 20 min (2 × 10 min) until both
bromophenol blue and acetaldehyde/chloranil tests were positive. HBTU activation was performed
with 2.5 equiv. of Fmoc-amino acid, 2.0 equiv. of HBTU, and 2.0 equiv. of HOAt in DMF (4 mL
for every equiv. of resin), with N,N-diisopropyl ethyl amine (DIPEA, 2 mL of a 1 M solution
in DMF for every equiv. of resin). Coupling was performed at room temperature for 1.5 h in a
sintered funnel with continuous stirring, and completeness was monitored by both bromophenol
blue and acetaldehyde/chloranil tests after thorough washes with DMF and DCM (Dichloromethane).
The final cleavage was obtained using a mixture of TFA/DCM/TIPS/water (47.5:47.5:2.5:2.5) (TFA:
trifluoroacetic acid; TIPS: triisopropyl silane). The crude peptide was too hydrophobic to be
precipitated in cold ether, thus the majority of TFA was evaporated under argon flow, and the
remaining oil was dissolved in a mixture of acetonitrile/water and then purified by reverse-phase
HPLC (Agilent Technologies, Santa Clara, CA, USA). The HPLC Agilent 1260 Infinity system was
equipped with a preparative gradient pump (1311B), semipreparative C-18 column (Kinetex, 5 microns,
100 Å, 250 mm × 10 mm, Phenomenex, Torrance, CA, USA), autosampler (G1329B), and Photodiode
Array detector (G1315C). The gradient used consisted of acetonitrile (MeCN)/water with 0.1% TFA
with the following program: t = 0–2 min, 25% MeCN; t = 12 min, 50% MeCN; t = 15 min, 95% MeCN;
t = 16 min, 95% MeCN (Retention time tR = 6.8 min). The compound was then freeze-dried to yield the
corresponding peptide as a white fluffy powder. Peptide identity was verified by ESI-MS, 1H-NMR,
and 13C-NMR [39].
4.3. Hydrogel Preparation
The peptide was dissolved in sodium phosphate buffer (0.1 M pH 11.8), and then diluted with
an equal volume of sodium phosphate at acidic pH (0.1 M pH 5.8) to a final peptide concentration
of 10 mM, obtaining a final pH of 7.2 ± 0.1. All buffer solutions were filtered (0.2 µm) prior to use.
In the case of the naproxen-containing hydrogels, in a typical protocol naproxene was dissolved
with 200 µL of 1 M NaOH and 150 µL sodium phosphate buffer (0.1 M pH 11.8), then the peptide
DLeu-Phe-Phe was added to achieve a final concentration of 10 mM of peptide, with another 150 µL of
sodium phosphate buffer (0.1 M pH 5.8) to obtain a final pH of 7.1 ± 0.1. All buffer solutions were
filtered (0.2 µm) prior to use. The final concentration of naproxene was 100 mg/mL. In the case of
the ketoprofen-containing hydrogels, ketoprofen was dissolved with 50 µL of 1 M NaOH and 200 µL
of sodium phosphate buffer (0.1 M pH 11.8), then the peptide DLeu-Phe-Phe was added to a final
concentration of 10 mM of peptide, with another 250 µL of sodium phosphate buffer (0.1 M pH 5.8)
to obtain a final pH of 7.1 ± 0.1. All buffer solutions were filtered (0.2 µm) prior to use. The final
concentration of ketoprofen was 25 mg/mL.
4.4. Oscillatory Rheometry
Dynamic time sweep rheological analysis was conducted on a Malvern Kinexus Ultra Plus
Rheometer (Alfatest, Milan, Italy) with a 20 mm stainless steel parallel plate geometry. The temperature
was maintained at 25 ◦C using a Peltier temperature controller (Alfatest, Milan, Italy). Samples were
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prepared in situ and immediately analysed with a gap of 1.00 mm. Time sweeps were recorded for
1 h, using a frequency of 1.00 Hz and a controlled stress of 2.00 Pa. After 1 h, frequency sweeps were
recorded using a controlled stress of 2.00 Pa, and then stress sweeps were recorded using a frequency
of 1 Hz.
4.5. Transmission Electron Microscopy
TEM micrographs were acquired on a Jeol, JEM 2100 (Tokyo, Japan) at 100 kV. TEM grids
(copper-grid-supported lacey carbon film) were first exposed to UV-ozone cleaner (UV-Ozone
Procleaner Plus, BioForce Nanosciences, Ames, IA, USA) for 45 min to make the grid surface more
hydrophilic. Then, 24 h-aged gels were precisely deposited on a TEM grid, dried for 15 min at room
temperature and contrasted by aqueous tungsten phosphate solution (pH 7.4). The average size of the
nanostructures was determined by taking into account at least 100 measurements.
4.6. Circular Dichroism
A 0.1 mm quartz cell was used on a Jasco J-815 Spectropolarimeter (Jasco Europe, Cremella, Italy),
with 1 s integrations, one accumulation, and a step size of 1 nm with a bandwidth of 1 nm over a range
of wavelengths from 190 to 280 nm at 25 ◦C unless otherwise stated. Samples were freshly prepared
directly in the CD cell and the spectra immediately recorded.
4.7. Fourier-Transformed Infrared Spectroscopy
FT-IR spectra were registered using the KBr-pellet method. The gel was prepared, and after 24 h
it was dried under vacuum. Then, it was mixed with KBr to make the pellet. Spectra were acquired at
1 cm−1 resolution and 128 accumulations on a Perkin Elmer System 2000 (Perkin Elmer, Milan, Italy).
4.8. Thioflavin T Fluorescence Assay
Gels (150 µL) were prepared directly inside the wells of Greiner 96 U Bottom Black Polystyrene
plates (VWR, Milan, Italy). After 1 h, 30 µL of a solution of Thioflavin T (22.2 M in 20 mM glycine-NaOH
pH 7.5, filtered with a 0.2 µm filter) were added into the wells. After 15 min, the fluorescence emission
was analysed using an Infinite M1000 pro (Tecan, Milan, Italy), selecting an excitation wavelength
of 446 nm and an emission wavelength of 490 nm, with a bandwidth of 20 nm. Each condition
was repeated twice in triplicate. The average and standard deviations were calculated and plotted
with Excel.
4.9. Drug Release Assay
Hydrogels were prepared as described above (0.500 mL total volume) in an amber glass vial,
and were left to self-assemble overnight. The following morning, 8 mL of phosphate-buffered saline
(PBS) were added on top, filling the vials. The vials were incubated at 37 ◦C, 60 rpm, and at various
timepoints. Fifty microliter (50 µL) samples were taken and added to 0.200 mL of water and analysed by
reverse-phase HPLC (absorbance at 254 nm, same program as described above for peptide purification).
Each experiment was repeated three times. The average and standard deviation values were calculated
and plotted with Excel.
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/3/3/29/s1.
Figure S1: Amide region of FT-IR spectra of drugs alone (a,b) and included in the peptide hydrogels (c,d).
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